@JaguarHealth
Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website | Jaguar Health, Inc.
Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website | Jaguar Health, Inc.
Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet | Jaguar Health, Inc.
Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Receives Second Tranche of Funding from One Small Planet | Jaguar Health, Inc.
Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications | Jaguar Health, Inc.
Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications | Jaguar Health, Inc.
The Investor Relations website contains information about Jaguar Health, Inc.'s business for stockholders, potential investors, and financial analysts.
Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference | Jaguar Health, Inc.
Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference | Jaguar Health, Inc.
Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption | Jaguar Health, Inc.
Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption | Jaguar Health, Inc.
Jaguar Health Reports Second Quarter 2023 Financial Results | Jaguar Health, Inc.
Jaguar Health Reports Second Quarter 2023 Financial Results | Jaguar Health, Inc.
The Investor Relations website contains information about Jaguar Health, Inc.'s business for stockholders, potential investors, and financial analysts.
Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea | Jaguar Health, Inc.
Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea | Jaguar Health, Inc.
Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease | Jaguar Health, Inc.
Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease | Jaguar Health, Inc.
Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea | Jaguar Health, Inc.
Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea | Jaguar Health, Inc.
REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th | Jaguar Health, Inc.
REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th | Jaguar Health, Inc.
Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS) | Jaguar Health, Inc.
Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS) | Jaguar Health, Inc.
The Investor Relations website contains information about Jaguar Health, Inc.'s business for stockholders, potential investors, and financial analysts.
In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon | Jaguar Health, Inc.
In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon | Jaguar Health, Inc.
The Investor Relations website contains information about Jaguar Health, Inc.'s business for stockholders, potential investors, and financial analysts.
Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs | Jaguar Health, Inc.
Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs | Jaguar Health, Inc.
Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" | Jaguar Health, Inc.
Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" | Jaguar Health, Inc.
Jaguar Health Reports Approval of All Proposals at 2023 Annual Meeting of Stockholders | Jaguar Health, Inc.
Jaguar Health Reports Approval of All Proposals at 2023 Annual Meeting of Stockholders | Jaguar Health, Inc.
The Investor Relations website contains information about Jaguar Health, Inc.'s business for stockholders, potential investors, and financial analysts.
Napo Pharmaceuticals, a Jaguar Health Company, Submits Investigational New Drug (IND) Application to FDA for Microvillus Inclusion Disease | Jaguar Health, Inc.
Napo Pharmaceuticals, a Jaguar Health Company, Submits Investigational New Drug (IND) Application to FDA for Microvillus Inclusion Disease | Jaguar Health, Inc.
First U.S.-Based Canine Cancer Registry, Founded by Jaguar Health, Joins International Network to Help Advance Canine and Human Cancer Research | Jaguar Health, Inc.
First U.S.-Based Canine Cancer Registry, Founded by Jaguar Health, Joins International Network to Help Advance Canine and Human Cancer Research | Jaguar Health, Inc.
Jaguar Health Launching AI-Driven Social Media Disease Awareness Education Series Regarding Cancer Therapy-Related Diarrhea in Dogs and People | Jaguar Health, Inc.
Jaguar Health Launching AI-Driven Social Media Disease Awareness Education Series Regarding Cancer Therapy-Related Diarrhea in Dogs and People | Jaguar Health, Inc.
The Investor Relations website contains information about Jaguar Health, Inc.'s business for stockholders, potential investors, and financial analysts.
Jaguar Health Subsidiary Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer (MASCC) | Jaguar Health, Inc.
Jaguar Health Subsidiary Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer (MASCC) | Jaguar Health, Inc.
Jaguar Health to Present June 21st at MedInvest Oncology Investor Conference | Jaguar Health, Inc.
Jaguar Health to Present June 21st at MedInvest Oncology Investor Conference | Jaguar Health, Inc.
Ladenburg Thalmann to Host Virtual Discussion June 22nd with Jaguar Health CEO and Leading Patient Advocates on Impact of Cancer Therapy-related Diarrhea on Patients & Importance of the Patient Voice in Supportive Care | Jaguar Health, Inc.
Ladenburg Thalmann to Host Virtual Discussion June 22nd with Jaguar Health CEO and Leading Patient Advocates on Impact of Cancer Therapy-related Diarrhea on Patients & Importance of the Patient Voice in Supportive Care | Jaguar Health, Inc.
Canine and Child Cancer Research Advocates Call for Support as Capitol Hill "Goes to the Dogs" | Jaguar Health, Inc.
Canine and Child Cancer Research Advocates Call for Support as Capitol Hill "Goes to the Dogs" | Jaguar Health, Inc.
European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, PhD Named Commander of the Italian Republic for Special Merits | Jaguar Health, Inc.
European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, PhD Named Commander of the Italian Republic for Special Merits | Jaguar Health, Inc.
Jaguar Announces Over-Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Jaguar Announces Over-Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Board Certified Patient Advocate Stacey Tinianov, MPH, Joins Jaguar Health's Scientific Advisory Board | Jaguar Health, Inc.
Board Certified Patient Advocate Stacey Tinianov, MPH, Joins Jaguar Health's Scientific Advisory Board | Jaguar Health, Inc.
Take C.H.A.R.G.E. Registry Marks One-Year Anniversary on National Canine Cancer Awareness Day, With Database Grown 40% | Jaguar Health, Inc.
Take C.H.A.R.G.E. Registry Marks One-Year Anniversary on National Canine Cancer Awareness Day, With Database Grown 40% | Jaguar Health, Inc.
Jaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health Panel | Jaguar Health, Inc.
Jaguar Health to Present at Lytham Partners Spring 2023 Investor Conference & Participate in Animal Health Panel | Jaguar Health, Inc.
Jaguar Health Reports First Quarter 2023 Financial Results | Jaguar Health, Inc.
Jaguar Health Reports First Quarter 2023 Financial Results | Jaguar Health, Inc.
REMINDER: Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
REMINDER: Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
Canalevia-CA1, Jaguar Animal Health’s FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs, Now Available from Chewy | Jaguar Health, Inc.
Canalevia-CA1, Jaguar Animal Health’s FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs, Now Available from Chewy | Jaguar Health, Inc.
Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription Drug | Jaguar Health, Inc.
Jaguar Health Launches AI-powered Web Portal to Support Patient Access to Mytesi, the Company's FDA-approved Prescription Drug | Jaguar Health, Inc.
Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates | Jaguar Health, Inc.
Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates | Jaguar Health, Inc.
Napo Therapeutics Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
Napo Therapeutics Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
U.S. Veterinary Oncologists Participating in a New Survey Prefer Canalevia-CA1 Over the Current Standard of Care | Jaguar Health, Inc.
U.S. Veterinary Oncologists Participating in a New Survey Prefer Canalevia-CA1 Over the Current Standard of Care | Jaguar Health, Inc.
Patient Enrollment Surpasses 90% in Jaguar Health's Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Patient Enrollment Surpasses 90% in Jaguar Health's Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Jaguar Health Provides Update on Monitoring Trading Activity to Identify Possible Illegal Short Selling | Jaguar Health, Inc.
Jaguar Health Provides Update on Monitoring Trading Activity to Identify Possible Illegal Short Selling | Jaguar Health, Inc.
Jaguar Animal Health Exhibiting at Veterinary Cancer Society Collaborative Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs | Jaguar Health, Inc.
Jaguar Animal Health Exhibiting at Veterinary Cancer Society Collaborative Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs | Jaguar Health, Inc.
Jaguar Health Reports 2022 Financial Results - Prescription Revenues up 179% to $11.9 Million | Jaguar Health, Inc.
Jaguar Health Reports 2022 Financial Results - Prescription Revenues up 179% to $11.9 Million | Jaguar Health, Inc.
Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT | Jaguar Health, Inc.
Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT | Jaguar Health, Inc.
Leading Cancer Patient Advocate Kelly Shanahan, M.D., Joins Jaguar Health's Scientific Advisory Board | Jaguar Health, Inc.
Leading Cancer Patient Advocate Kelly Shanahan, M.D., Joins Jaguar Health's Scientific Advisory Board | Jaguar Health, Inc.
Jaguar Health to Hold Investor Webcast Monday, March 27th at 8:30 AM EDT Regarding Q4 2022 Financials & Corporate Updates | Jaguar Health, Inc.
Jaguar Health to Hold Investor Webcast Monday, March 27th at 8:30 AM EDT Regarding Q4 2022 Financials & Corporate Updates | Jaguar Health, Inc.
Jaguar Health Celebrates U.N. International Day of Forests with Milestone of Providing Income to 20,000+ People Living in Tropical Rainforest Communities | Jaguar Health, Inc.
Jaguar Health Celebrates U.N. International Day of Forests with Milestone of Providing Income to 20,000+ People Living in Tropical Rainforest Communities | Jaguar Health, Inc.
Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company's FDA-Approved Prescription Drug | Jaguar Health, Inc.
Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company's FDA-Approved Prescription Drug | Jaguar Health, Inc.
Jaguar Health to Present at BioTrinity 2023 Conference’s R&D Spotlight on Rare Diseases | Jaguar Health, Inc.
Jaguar Health to Present at BioTrinity 2023 Conference’s R&D Spotlight on Rare Diseases | Jaguar Health, Inc.
FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US | Jaguar Health, Inc.
FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US | Jaguar Health, Inc.
Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer | Jaguar Health, Inc.
Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer | Jaguar Health, Inc.
Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea | Jaguar Health, Inc.
Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A. | Jaguar Health, Inc.
Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A. | Jaguar Health, Inc.
Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement | Jaguar Health, Inc.
Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement | Jaguar Health, Inc.
Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development | Jaguar Health, Inc.
Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development | Jaguar Health, Inc.
Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling | Jaguar Health, Inc.
Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling | Jaguar Health, Inc.
Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise | Jaguar Health, Inc.
Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise | Jaguar Health, Inc.
Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe | Jaguar Health, Inc.
Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe | Jaguar Health, Inc.
Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer | Jaguar Health, Inc.
Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer | Jaguar Health, Inc.
Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences | Jaguar Health, Inc.
Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences | Jaguar Health, Inc.
Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders | Jaguar Health, Inc.
Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders | Jaguar Health, Inc.
Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st | Jaguar Health, Inc.
Jaguar Health to Present at Lytham Partners Investor Select Conference on January 31st | Jaguar Health, Inc.
REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar’s Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Deriv
REMINDER: Jaguar Health to Hold Investor Webcast Thursday, January 12th at 10:30 AM EST to Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Jaguar’s Mental Health Entheogen Therapeutics Initiative (ETI) to Discover Novel Therapies Deriv
Sandra M. Swain, MD, FACP, FASCO Joins Jaguar Health's Scientific Advisory Board | Jaguar Health, Inc.
Sandra M. Swain, MD, FACP, FASCO Joins Jaguar Health's Scientific Advisory Board | Jaguar Health, Inc.
Jaguar to Hold Investor Webcast Thursday, Jan 12, 2023 at 10:30 AM EST to Highlight Unmet Medical Need of CTD and Jaguar's Mental Health Entheogen Therapeutics Initiative to Discover Novel Therapies Derived from Psychoactive Plants
Jaguar to Hold Investor Webcast Thursday, Jan 12, 2023 at 10:30 AM EST to Highlight Unmet Medical Need of CTD and Jaguar's Mental Health Entheogen Therapeutics Initiative to Discover Novel Therapies Derived from Psychoactive Plants
Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health Illnesses | Jaguar Health, Inc.
Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health Illnesses | Jaguar Health, Inc.
Jaguar Health Provides Updates on Presentation at the World Congress of Gastroenterology About Crofelemer for Pediatric Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDD) by Third-Party Investigator | Jaguar Health, Inc.
Jaguar Health Provides Updates on Presentation at the World Congress of Gastroenterology About Crofelemer for Pediatric Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDD) by Third-Party Investigator | Jaguar Health, Inc.
The Gayly Dose Podcast - World AIDS Day
The Gayly Dose Podcast - World AIDS Day
Jaguar Health Hosts Symposium on the Management of Cancer Therapy-related Diarrhea | Jaguar Health, Inc.
Jaguar Health Hosts Symposium on the Management of Cancer Therapy-related Diarrhea | Jaguar Health, Inc.
Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials | Jaguar Health, Inc.
Jaguar Health Provides Company Updates and Reports 2022 Third Quarter Financials | Jaguar Health, Inc.
Jaguar Health to Host Investor Webcast Monday, November 14th at 8:30 AM Eastern Time Regarding Q3 2022 Financials & Corporate Updates | Jaguar Health, Inc.
Jaguar Health to Host Investor Webcast Monday, November 14th at 8:30 AM Eastern Time Regarding Q3 2022 Financials & Corporate Updates | Jaguar Health, Inc.
Jaguar Animal Health Sponsors October 26th Episode of dvm360 Live! to Drive Awareness of Canalevia-CA1 and Participation in Jaguar’s Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) Initiative | Jaguar Health, Inc.
Jaguar Animal Health Sponsors October 26th Episode of dvm360 Live! to Drive Awareness of Canalevia-CA1 and Participation in Jaguar’s Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) Initiative | Jaguar Health, Inc.
Jaguar Health Announces Publication in Breast Cancer Research and Treatment of Investigator-Initiated Phase 2 HALT-D Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients | Jaguar Health, Inc.
Jaguar Health Announces Publication in Breast Cancer Research and Treatment of Investigator-Initiated Phase 2 HALT-D Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients | Jaguar Health, Inc.
European Medicines Agency Grants Orphan Drug Designation for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication | Jaguar Health, Inc.
European Medicines Agency Grants Orphan Drug Designation for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication | Jaguar Health, Inc.
Jaguar Animal Health Co-Sponsoring Closing Ceremony at Veterinary Cancer Society Annual Conference on October 15th to Drive Awareness of Jaguar's Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) Initiative
Jaguar Animal Health Co-Sponsoring Closing Ceremony at Veterinary Cancer Society Annual Conference on October 15th to Drive Awareness of Jaguar's Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) Initiative
Jaguar Health Reports Voting Results from 2022 Special Meeting of Stockholders; All Proposals Approved
Jaguar Health Reports Voting Results from 2022 Special Meeting of Stockholders; All Proposals Approved
Jaguar Health Subsidiary Napo Pharmaceuticals Announces Activation by FDA of Investigational New Drug (IND) Application for NP-300, a Novel Drug Candidate for the Symptomatic Relief and Treatment of Diarrhea from Cholera and Other Pathogens
Jaguar Health Subsidiary Napo Pharmaceuticals Announces Activation by FDA of Investigational New Drug (IND) Application for NP-300, a Novel Drug Candidate for the Symptomatic Relief and Treatment of Diarrhea from Cholera and Other Pathogens
Jaguar Health to Present at Lytham Partners Fall 2022 Investor Conference on September 28th and at Ladenburg Thalmann 2022 Healthcare Conference on September 29th
Jaguar Health to Present at Lytham Partners Fall 2022 Investor Conference on September 28th and at Ladenburg Thalmann 2022 Healthcare Conference on September 29th
Jaguar Health Announces Submission of Investigational New Drug (IND) Application to FDA for Drug Candidate for the Symptomatic Relief of Diarrhea from Cholera
Jaguar Health Announces Submission of Investigational New Drug (IND) Application to FDA for Drug Candidate for the Symptomatic Relief of Diarrhea from Cholera
Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream
Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream
Jaguar Health Announces that Orphan Drug Designation Application Submitted to the FDA for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Has Been Accepted for Review
Jaguar Health Announces that Orphan Drug Designation Application Submitted to the FDA for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Has Been Accepted for Review
Jaguar Health Provides Company Updates and Reports 2022 Second Quarter Financials. REMINDER: Jaguar to host investor webcast Monday, August 22nd at 8:30 a.m. Eastern regarding second quarter 2022 financials and company updates.
Jaguar Health Provides Company Updates and Reports 2022 Second Quarter Financials. REMINDER: Jaguar to host investor webcast Monday, August 22nd at 8:30 a.m. Eastern regarding second quarter 2022 financials and company updates.
Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq's Bid Price Rule
Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq's Bid Price Rule
Jaguar Health to Host Investor Webcast Monday, August 22nd at 8:30 AM Eastern Time Regarding Q2 2022 Financials & Corporate Updates
Jaguar Health to Host Investor Webcast Monday, August 22nd at 8:30 AM Eastern Time Regarding Q2 2022 Financials & Corporate Updates
Gallup Survey Estimates Nearly 30 Million U.S. Dog Owners Have Experienced Canine Cancer, with Many Saying it Negatively Impacted Their Own Quality of Life
Gallup Survey Estimates Nearly 30 Million U.S. Dog Owners Have Experienced Canine Cancer, with Many Saying it Negatively Impacted Their Own Quality of Life
Jaguar Health Announces Issuance of U.S. Patent 11,389,424, a Methods and Compositions Patent for Treating Chemotherapy-Induced Diarrhea | Jaguar Health, Inc.
Jaguar Health Announces Issuance of U.S. Patent 11,389,424, a Methods and Compositions Patent for Treating Chemotherapy-Induced Diarrhea | Jaguar Health, Inc.
Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
HIV Long-Term Survivors Awareness Day June 5
HIV Long-Term Survivors Awareness Day June 5
Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week | Jaguar Health, Inc.
Jaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week | Jaguar Health, Inc.
Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index | Jaguar Health, Inc.
Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index | Jaguar Health, Inc.
RSVP Here: Take C.H.A.R.G.E. Canine Cancer Registry Launch Event (In-Person and Virtual)
RSVP Here: Take C.H.A.R.G.E. Canine Cancer Registry Launch Event (In-Person and Virtual)
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd! | Jaguar Health, Inc.
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd! | Jaguar Health, Inc.
Matico - Medicinal Plant Series | Botanical Online
Matico - Medicinal Plant Series | Botanical Online
TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health | Jaguar Health, Inc.
TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health | Jaguar Health, Inc.
Jaguar Health Announces Launch of Mytesi Telehealth Program | Jaguar Health, Inc.
Jaguar Health Announces Launch of Mytesi Telehealth Program | Jaguar Health, Inc.
Jaguar Health Canine Cancer: Take C.H.A.R.G.E. May 23rd Launch Event
Jaguar Health Canine Cancer: Take C.H.A.R.G.E. May 23rd Launch Event
Jaguar Health Provides Company Updates and Reports 2022 First Quarter Financials | Jaguar Health, Inc.
Jaguar Health Provides Company Updates and Reports 2022 First Quarter Financials | Jaguar Health, Inc.
Women's Empowerment Conference: A Catalyst for Gender Equality
Women's Empowerment Conference: A Catalyst for Gender Equality
Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates | Jaguar Health, Inc.
Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates | Jaguar Health, Inc.
Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs | Jaguar Health, Inc.
Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs | Jaguar Health, Inc.
National Minority Health Month 2022
National Minority Health Month 2022
Stop the Destruction of Our Rainforests
Stop the Destruction of Our Rainforests
Jaguar Animal Health Announces Commercial Availability of Plant-based Canalevia-CA1 (Crofelemer) Prescription Drug for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs | Jaguar Health, Inc.
Jaguar Animal Health Announces Commercial Availability of Plant-based Canalevia-CA1 (Crofelemer) Prescription Drug for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs | Jaguar Health, Inc.
Pastel de Tres Leches Cake | The Spruce Eats
Pastel de Tres Leches Cake | The Spruce Eats
Earth Day 2022 | Invest in Our Planet™
Earth Day 2022 | Invest in Our Planet™
Jaguar Health to Present at the NobleCon18 Investor Conference on April 21, 2022 | Jaguar Health, Inc.
Jaguar Health to Present at the NobleCon18 Investor Conference on April 21, 2022 | Jaguar Health, Inc.
Bicycle Day: Honoring The Onset Of The Psychedelic Revolution As It Zooms Across The Globe
Bicycle Day: Honoring The Onset Of The Psychedelic Revolution As It Zooms Across The Globe
NobleCon18 | Register
NobleCon18 | Register
12 Benefits of Ginkgo Biloba | Medicinal Plant Series
12 Benefits of Ginkgo Biloba | Medicinal Plant Series
Diarrhea | Cancer-related Side Effects | American Cancer Society
Diarrhea | Cancer-related Side Effects | American Cancer Society
Our Team | Jaguar Health
Our Team | Jaguar Health
Sopa Criolla (Beef And Angel Hair Soup) | Peru Delights
Sopa Criolla (Beef And Angel Hair Soup) | Peru Delights
30 Amazing Things You Didn't Know You Could Recycle | Conserve Energy Future
30 Amazing Things You Didn't Know You Could Recycle | Conserve Energy Future
International Day of Forests | United Nations
International Day of Forests | United Nations
Brent Sass wins his 1st Iditarod sled dog race across Alaska
Brent Sass wins his 1st Iditarod sled dog race across Alaska
Echinacea | Benefits, Uses, Side Effects and Dosage
Echinacea | Benefits, Uses, Side Effects and Dosage
Eye on the Trail: The Eighth Day
Eye on the Trail: The Eighth Day
Iditarod Race News Center
Iditarod Race News Center
Eye on the Trail | Last Teams to Finish March 17th
Eye on the Trail | Last Teams to Finish March 17th
Eye on the Trail | Burmeister First to McGrath
Eye on the Trail | Burmeister First to McGrath
International Women's Day 2022 theme | Break the Bias
International Women's Day 2022 theme | Break the Bias
Jaguar Health CEO Lisa Conte | From Rainforest to Laboratory
Jaguar Health CEO Lisa Conte | From Rainforest to Laboratory
What is Rare Disease Day? | Rare Disease Day 2022
What is Rare Disease Day? | Rare Disease Day 2022
Peruvian Arroz con Leche: Scrumptious Peruvian Rice Pudding | EatPeru
Peruvian Arroz con Leche: Scrumptious Peruvian Rice Pudding | EatPeru
#ThankYouPlantMedicine Movement | Destigmatizing Plant Medicine
#ThankYouPlantMedicine Movement | Destigmatizing Plant Medicine
Register for CID Treatment Forum on March 6, 2022 | Canalevia
Register for CID Treatment Forum on March 6, 2022 | Canalevia
Peruvian Pork Loin Adobo Recipe | EatPeru
Peruvian Pork Loin Adobo Recipe | EatPeru
World Cancer Day
World Cancer Day
Budín de Pan - Sweet Peruvian Bread Pudding | EatPeru
Budín de Pan - Sweet Peruvian Bread Pudding | EatPeru
jimsonweed | Plant, Hallucinogen, Poisonous, & Facts
jimsonweed | Plant, Hallucinogen, Poisonous, & Facts
Huancaina Macaroni | EatPeru
Huancaina Macaroni | EatPeru
Register for CID Treatment Forum | Canalevia
Register for CID Treatment Forum | Canalevia
Rauvolfia serpentina - Overview | ScienceDirect Topics
Rauvolfia serpentina - Overview | ScienceDirect Topics
8 Tips to Green Your Holiday | Earth Day
8 Tips to Green Your Holiday | Earth Day
Amazon Heart of Palm Salad | Global Gastros
Amazon Heart of Palm Salad | Global Gastros
400th Anniversary of the first Pilgrim Thanksgiving in 1621 | The Washington Post
400th Anniversary of the first Pilgrim Thanksgiving in 1621 | The Washington Post
Ají de Gallina: Peruvian Spicy Creamed Chicken | The Spruce Eats
Ají de Gallina: Peruvian Spicy Creamed Chicken | The Spruce Eats
Picarones Recipe | EatPeru
Picarones Recipe | EatPeru
Resources for Pet Owners | Veterinary Cancer Society
Resources for Pet Owners | Veterinary Cancer Society
2021 International Jaguar Day Educational Awareness Contest
2021 International Jaguar Day Educational Awareness Contest
Jaguar Health's Lisa Conte - An Entrepreneurial Ascent Like No Other
Jaguar Health's Lisa Conte - An Entrepreneurial Ascent Like No Other
Causa Limeña de Pollo | EatPeru
Causa Limeña de Pollo | EatPeru
A Tough Business Lesson To Learn
A Tough Business Lesson To Learn
Breast Cancer Awareness Month | National Breast Cancer Foundation
Breast Cancer Awareness Month | National Breast Cancer Foundation
Aguadito De Pollo (Peruvian Chicken Soup) | Gimme Some Oven
Aguadito De Pollo (Peruvian Chicken Soup) | Gimme Some Oven
CEO Advice From A 30-Year Pharma Veteran
CEO Advice From A 30-Year Pharma Veteran
Healthcare: September 29-30 - Benzinga Small Cap Conference
Healthcare: September 29-30 - Benzinga Small Cap Conference
World Rivers Day
World Rivers Day
Rocoto Relleno - Peruvian Stuffed Peppers | EatPeru
Rocoto Relleno - Peruvian Stuffed Peppers | EatPeru
2021 Indigenous Peoples’ Day Educational Awareness Contest
2021 Indigenous Peoples’ Day Educational Awareness Contest
Peruvian Beans | Cook Eat Live Love
Peruvian Beans | Cook Eat Live Love
Guide to Honoring 9/11 in Your Community
Guide to Honoring 9/11 in Your Community
Medicinal Plant Series | Curare History
Medicinal Plant Series | Curare History
Vegan Peruvian Burritos | Feasting at Home
Vegan Peruvian Burritos | Feasting at Home
Red Lapacho | ScienceDirect
Red Lapacho | ScienceDirect
Arroz Chaufa | Whisk It Real Gud
Arroz Chaufa | Whisk It Real Gud
International Orangutan Day
International Orangutan Day
Lomo Saltado | EatPeru
Lomo Saltado | EatPeru
2021 African Traditional Medicine Day Educational Awareness Contest
2021 African Traditional Medicine Day Educational Awareness Contest
International Day of the World's Indigenous Peoples | United Nations
International Day of the World's Indigenous Peoples | United Nations
Peruvian Chopped Salad | The Cookie Rookie
Peruvian Chopped Salad | The Cookie Rookie
Paltas Rellenas | Peru Delights
Paltas Rellenas | Peru Delights
Amazon Rainforest Facts | Mongabay
Amazon Rainforest Facts | Mongabay
Papa a la Huancaína | Caroline's Cooking
Papa a la Huancaína | Caroline's Cooking
Plastic Free July
Plastic Free July
Peruvian Chicken with Green Sauce | Feasting at Home
Peruvian Chicken with Green Sauce | Feasting at Home
It Gets Better Project | Education
It Gets Better Project | Education
Peruvian Quinoa Salad | Global Table Adventure
Peruvian Quinoa Salad | Global Table Adventure
Medicinal Plants Educational Awareness Contest
Medicinal Plants Educational Awareness Contest
Banisteriopsis caapi History
Banisteriopsis caapi History
Juneteenth History | NMAAHC
Juneteenth History | NMAAHC
Plantain Nutrition Benefits
Plantain Nutrition Benefits
Cancer Survivors Quiz | AACR
Cancer Survivors Quiz | AACR
Medicinal Plant Series | Cinchona Tree
Medicinal Plant Series | Cinchona Tree
Resources | The Trevor Project
Resources | The Trevor Project
Jaguar Conservation Program + Coffee
Jaguar Conservation Program + Coffee
View on mobile
